Drugs / GTO®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07047131 | Dec 2018 → Dec 2025 overdue | periodontal disorder | Marco Esposito | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GTO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07047131 ↗ |